Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

There are three populations in Recombinant Mycobacterium tuberculosis Vaccine Freeze-dried (AEC/BC02) phase I clinical research. The clinical study adopt randomized and open research design. Population I have 25 subjects who received Tuberculin purified protein derivative(TB-PPD) skin test and specific gamma-interferon (γ-IFN)detection whose results are both negative ;Population II have 75 subjects who received Tuberculin purified protein derivative(TB-PPD) and ESAT6-CFP10 skin test in different arms , specific gamma-interferon (γ-IFN) detection whose results are all negative.75 subjects whose three kinds of detection results are all positive(specific gamma interferon detection (γ-IFN),TB-PPD and ESAT6-CFP10 ) are named as population III. Three populations are screened at the same time. After filtrating, injecting of population I start firstly.After ensure the safety of the population I population II and population III carry out the implementation at the same time.

Provided treatments

  • Biological: Placebo
  • Biological: Low dose adjuvant
  • Biological: High dose adjuvant
  • Biological: Low dose vaccine
  • Biological: High dose vaccine
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03026972. The sponsor of the trial is Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. and it is looking for 135 volunteers for the current phase.
Official trial title:
A Phase ⅠStudy of the Human Body Tolerance Research of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried